LEADER 03618nam  2200973z- 450 
001 9910557739303321
005 20231214133217.0
035   $a(CKB)5400000000045950
035   $a(oapen)https://directory.doabooks.org/handle/20.500.12854/76422
035   $a(EXLCZ)995400000000045950
100   $a20202201d2021      |y             0
101 0 $aeng
135   $aurmn|---annan
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aPolymeric Carriers for Biomedical and Nanomedicine Application
210   $aBasel, Switzerland$cMDPI - Multidisciplinary Digital Publishing Institute$d2021
215   $a1 electronic resource (186 p.)
311   $a3-0365-1173-3 
311   $a3-0365-1172-5 
330   $aThis book focuses on the design of polymeric delivery systems for biomedical and nanomedicine applications as well as on understanding how such biomaterials interact in the physiological environment. The reader will find an encompassing view on the state-of-the-art of polymeric carriers, showing how current research deals with new stimuli-responsive systems for cancer therapies and biomedical challenges, namely overcoming the skin barrier. The published papers cover topics ranging from novel production methods and insights on hybrid polymers to applications as diverse as nanoparticles, hydrogels and microneedles for antifungal skin therapy, peptide and siRNA delivery, enhanced skin absorption of bioactive molecules, and anticancer therapy. The book comprises one review paper and nine research papers.
606   $aTechnology: general issues$2bicssc
610   $aosteoarthritis
610   $amonosodium iodoacetate
610   $ap47phox
610   $aPLGA nanoparticles
610   $areactive oxygen species
610   $afull factorial design
610   $aoptimization
610   $ametronidazole
610   $ananocomposites
610   $asodium alginate
610   $achitosan
610   $aPLGA
610   $ahybrid polymers
610   $achitosan-PLGA polymer
610   $aNMR
610   $aDSC
610   $aFT-IR
610   $acovalent drug conjugation
610   $atherapeutic nanodevice
610   $apolymeric nanoparticles
610   $acancer therapy
610   $acontrolled drug delivery
610   $aredox responsive PEG-block-PLA
610   $ananocarriers
610   $adisulfide bond
610   $acontrolled release
610   $aretinol
610   $ananosponge
610   $ahydrogel
610   $aBox-Behnken design
610   $apharmacokinetic
610   $aterbinafine hydrogel
610   $aniacinamide
610   $apolyethene glycol (PEG) 400
610   $asolvent
610   $adermal delivery
610   $afinite dose
610   $aporcine skin
610   $adissolving microneedles
610   $amultiple sclerosis
610   $aPLP
610   $atransdermal delivery
610   $atyrosol
610   $ananoparticles
610   $aDesign of Experiment (DoE)
610   $a? cyclodextrin
610   $aDNA binding
610   $aglyconanoparticles
610   $aimmunotherapy
610   $ainfectious diseases
610   $amannose receptors
610   $anutraceuticals
615  7$aTechnology: general issues
700   $aLima$b Sofia$4edt$01328371
702   $aReis$b Salette$4edt
702   $aLima$b Sofia$4oth
702   $aReis$b Salette$4oth
906   $aBOOK
912   $a9910557739303321
996   $aPolymeric Carriers for Biomedical and Nanomedicine Application$93038544
997   $aUNINA